2016
DOI: 10.1002/jlcr.3445
|View full text |Cite
|
Sign up to set email alerts
|

Carbon‐14 radiolabeling and tissue distribution evaluation of MMV390048

Abstract: The antimalarial compound MMV390048 ([ C]-11) was labeled with carbon-14 isotope via a 3-step synthesis. It was obtained in a 15.5% radiochemical overall yield from carbon-14 labeled methyl iodide with a radiochemical purity of >99%. After single oral administration of [ C]-11 to albino and pigmented rats its tissue distribution profile was studied. Tissue distribution results showed high local exposure in the GI tract and excretory organs but low exposure of all other tissues. The radioactivity uptake was hig… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 22 publications
0
3
0
Order By: Relevance
“…The latter reagent was also used to synthesize difluoromethylated compound 11 as described in detail in the Experimental Section. The noncommercial sulfoxides 3c , 4c , 5c , and 6c and sulfones 3d , 4d , 5d , and 6d were prepared by oxidation of the corresponding sulfides using previously reported procedures . The noncommercial sulfide 6b and the difluoromethylated compounds 5a , 9 , and 7 were prepared according to previously published methods.…”
Section: Results and Discussionmentioning
confidence: 99%
“…The latter reagent was also used to synthesize difluoromethylated compound 11 as described in detail in the Experimental Section. The noncommercial sulfoxides 3c , 4c , 5c , and 6c and sulfones 3d , 4d , 5d , and 6d were prepared by oxidation of the corresponding sulfides using previously reported procedures . The noncommercial sulfide 6b and the difluoromethylated compounds 5a , 9 , and 7 were prepared according to previously published methods.…”
Section: Results and Discussionmentioning
confidence: 99%
“…In a move away from conventional medicinal chemistry lectures, Dr. Molahleni Sonopo (South African Nuclear Energy Corporation, NECSA) discussed strategies to incorporate 14 C radiolabels into biologically active compounds for ADME investigations …”
Section: Medicinal Chemistry and Drug Discoverymentioning
confidence: 99%
“…This is a very logical and efficient sequence of bond disconnects, and it excels for a given policy which seeks to provide access to a diverse range of biologically active structures. All syntheses to date have relied upon this approach. , …”
mentioning
confidence: 99%